Catalyst Pharmaceuticals SG&A Expense (Annual) Insights

Catalyst Pharmaceuticals Inc (CPRX)

19.56 -0.39 (-1.95%) USD | NASDAQ | Sep 27, 16:00

19.58 +0.02 (+0.10%) After-Hours: 20:00

SG&A Expense (Annual) Chart

Historical SG&A Expense (Annual) Data

View and export this data back to 2004. Upgrade now.

Date	Value
December 31, 2023	133.71M
December 31, 2022	57.08M
December 31, 2021	49.63M
December 31, 2020	44.23M
December 31, 2019	36.88M
December 31, 2018	15.88M
December 31, 2017	7.304M
December 31, 2016	7.910M
December 31, 2015	8.597M
December 31, 2014	4.474M

Date	Value
December 31, 2013	2.215M
December 31, 2012	2.562M
December 31, 2011	2.698M
December 31, 2010	2.206M
December 31, 2009	2.178M
December 31, 2008	2.184M
December 31, 2007	2.036M
December 31, 2006	1.913M
December 31, 2005	0.4917M
December 31, 2004	0.1647M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Annual) Range, Past 5 Years

36.88M

Minimum

2019

133.71M

Maximum

2023

64.31M

Average

49.63M

Median

2021

SG&A Expense (Annual) Benchmarks